The immunohistochemical data come from a putative prostate cancer biomarker, LIM kinase 1 (LIMK1).3 In this study, the expression profile of LIMK1 was determined using a prostate tumor tissue array comprising 50 samples from tumors at different stages of progression. Here, LIMK1 is linked to prostate carcinoma.